Adage Capital Management, Bain Capital, Blackstone, New Enterprise Associates, Novartis Venture Funds, Satter Investment Management, Surveyor Capital
Company Description
Annexon Biosciences is pioneering the development of first-in-class therapeutic products that halt the progression of complement-mediated neurodegeneration (CMND). Backed by a team of experts in CMND, Annexon's mission is to rapidly advance disease-modifying therapies for patients with acute and chronic neurodegenerative disorders.
Market
Neurodegenerative Disorders
Location
South San Francisco,
California,
USA
Coinvestors
Clarus Ventures, Correlation Ventures, Novartis Venture Funds, Satter Investment Management